From: Serum nesfatin-1 is a biomarker of pre-diabetes and interplays with cardiovascular risk factors
Diabetic group (n = 30) | Pre-diabetic group (n = 30) | Healthy subjects (n = 28) | ||||
---|---|---|---|---|---|---|
r | P | r | P | r | P | |
Age (years) | 0.032 | 0.868 | − 0.240 | 0.200 | 0.060 | 0.755 |
Waist circumference (cm) | − 0.285 | 0.126 | 0.203 | 0.283 | 0.054 | 0.779 |
Waist/ hip ratio | 0.295 | 0.114 | 0.094 | 0.622 | − 0.027 | 0.889 |
Body mass index (kg/m2) | 0.221 | 0.241 | − 0.178 | 0.346 | − 0.265 | 0.157 |
Systolic blood pressure (mmHg) | − 0.490 | 0.006* | − 0.531 | 0.003* | − 0.127 | 0.505 |
Diastolic blood pressure (mmHg) | − 0.033 | 0.864 | 0.339 | 0.067 | 0.170 | 0.369 |
Fasting plasma glucose (mg/dl) | − 0.619 | < 0.001* | − 0.454 | 0.012* | − 0.095 | 0.618 |
2hPP plasma glucose (mg/dl) | − 0.390 | 0.033* | − 0.523 | 0.003* | − 0.226 | 0.229 |
Hemoglobin A1c(%) | − 0.447 | 0.013* | − 0.601 | < 0.001* | − 0.239 | 0.203 |
Fasting insulin (μU/mL | − 0.515 | 0.004* | − 0.569 | 0.001* | 0.128 | 0.499 |
HOMA-IR | − 0.406 | 0.026* | − 0.428 | 0.018* | 0.162 | 0.392 |
Total cholesterol (mg/dl) | − 0.549 | 0.002* | − 0.440 | 0.015* | − 0.279 | 0.136 |
Triglycerides (mg/dl) | − 0.503 | 0.005* | − 0.518 | 0.003* | − 0.242 | 0.197 |
High-density lipoprotein (mg/dl) | 0.573 | 0.001* | 0.562 | 0.001* | 0.265 | 0.156 |
Low-density lipoprotein (mg/dl) | − 0.419 | 0.021* | − 0.543 | 0.002* | − 0.298 | 0.109 |